Rolida, Ramel D.

HRN: 04-18-56  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/31/2025
09/07/2025
IV
600MG
Q8H
CELLULTIS
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines